Piper Sandler analyst John Barnidge downgraded MetLife (MET) to Neutral from Overweight with an unchanged price target of $84. The firm believes the shares are nearing fair value, trading less than 10% from the price target Many of MetLife’s catalysts are known at this time, like Chariot Re’s capabilities and the breaking out of the financials of MetLife Investment Management, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET:
- MetLife Advises Against Potemkin’s Mini-Tender Offer
- Wolfe Research launches coverage with positive view on Life Insurance names
- MetLife recommends that shareholders reject mini-tender by Potemkin Limited
- MetLife initiated with an Outperform at Wolfe Research
- MetLife Announces Redemption of Preferred Stock Series G